Growth and use of methylphenidate in the child and adolescent population: Systematic review
DOI:
https://doi.org/10.56294/piii2023174Keywords:
Methylphenidate, Children, Growth, Hyperactivity disorder, Development, Attention deficitAbstract
Background: Methylphenidate (MFD) is a drug widely used in the world for the treatment of ADHD (attention deficit hyperactivity disorder). Several adverse effects have been reported with its use, such as growth retardation in the pediatric population, but the available scientific evidence is limited, and a consensus has not yet been reached to determine whether MFD really produces such an effect.
Material and methods: A search in PubMed, Cochrane Library, academic Google and a synthesis of available evidence on the growth and use of methylphenidate in the child and adolescent population were analyzed through a Systematic Review type study where previous publications were analyzed. Results: 07 articles have been selected to evaluate the effect of methylphenidate on growth in infants and adolescents to assess the impact of growth in such a population. Conclusion: It is concluded that there is insufficient evidence on the affectation of growth, there are no long-term studies to confirm this action, in such a way that it cannot be affirmed that there is an important weight loss in the growth of children and adolescents
References
Storebø OJ, Rosendal S, Skoog M, Groth C, Bille T, Buch Rasmussen K, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents. En: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 2012 [citado 1 de diciembre de 2022]. p. CD009885. Disponible en: https://doi.wiley.com/10.1002/14651858.CD009885
Banaschewski T, Buitelaar J, Chui CSL, Coghill D, Cortese S, Simonoff E, et al. Methylphenidate for ADHD in children and adolescents: throwing the baby out with the bathwater. Evid Based Ment Health. noviembre de 2016;19(4):97-9.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. septiembre de 2018;5(9):727-38.
Vargas Rodríguez AM. Controversias frente al tratamiento farmacológico del TDAH entre padres y educadores de niños y adolescentes de Bogotá. Rev Iberoam Psicol. 10 de junio de 2020;13(2):13-24.
Palomino M aD, Guerrero CP, Martín-Calero M aJ. Tratamiento actual del trastorno por déficit de atención e hiperactividad (TDAH). :10.
Pereira Ribeiro J, Arthur EJ, Gluud C, Simonsen E, Storebø OJ. Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder? Pediatr Rep. 1 de agosto de 2021;13(3):434-43.
Espadas Tejerina M, Insa Pineda I, Chamorro Fernández M, Alda Díez JÁ. Efectos secundarios del metilfenidato en población infantil y juvenil. Rev Neurol. 2018;66(05):157.
Mulder R, Hazell P, Rucklidge JJ, Malhi GS. Methylphenidate for attention-deficit/hyperactivity disorder: Too much of a good thing? Aust N Z J Psychiatry. febrero de 2016;50(2):113-4.
Pliszka SR, Matthews TL, Braslow KJ, Watson MA. Comparative Effects of Methylphenidate and Mixed Salts Amphetamine on Height and Weight in Children With Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. mayo de 2006;45(5):520-6.
Carucci S, Balia C, Gagliano A, Lampis A, Buitelaar JK, Danckaerts M, et al. Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis. Neurosci Biobehav Rev. enero de 2021;120:509-25.
Zhang H, Du M, Zhuang S. Impact of Long-Term Treatment of Methylphenidate on Height and Weight of School Age Children with ADHD. Neuropediatrics. agosto de 2010;41(02):55-9.
Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R. Stimulant Treatment Over 5 Years: Effects on Growth. J Am Acad Child Adolesc Psychiatry. abril de 2006;45(4):415-21.
Zachor DA, Roberts AW, Bart Hodgens J, Isaacs JS, Merrick J. Effects of long-term psychostimulant medication on growth of children with ADHD. Res Dev Disabil. marzo de 2006;27(2):162-74.
Storebø OJ, Krogh HB, Ramstad E, Moreira-Maia CR, Holmskov M, Skoog M, et al. Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. BMJ. 25 de noviembre de 2015;h5203.
Waxmonsky JG, Pelham WE, Baweja R, Hale D, Pelham WE. Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. J Pediatr. febrero de 2022;241:115-125.e2.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Marília Guimarães de Sousa Jota, Analía Claudia Sabattini (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
